LGBTQI AND HIV HEROES HONOURED AT APCOM HERO AWARDS 2021

Born and raised in the Netherlands by loving and supportive parents whose lives and values were…

The COVID vaccine pioneer behind southeast Asia’s first mRNA shot

ChulaCov19 designer Kiat Ruxrungtham talks about his aim to make Thailand an mRNA vaccine hub, and…

What people living with HIV need to know about HIV and COVID-19

COVID-19 is a serious disease and all people living with HIV should take all recommended preventive…

UNAIDS Board adopts new global AIDS strategy which paves the way to end AIDS by 2030

From: UNAIDS The new Global AIDS Strategy 2021–2026, End Inequalities, End AIDS, is a bold approach…

In Memoriam: Professor Dr Charles Boucher

From: Erasmus MC In the early morning of February 26, Prof Dr Charles Boucher (63) passed…

END INEQUALITIES – Zero Discrimination Day – 1 March 2021

From: UNAIDS On Zero Discrimination Day this year (download brochure), UNAIDS is highlighting the urgent need…

Sysmex (Thailand) Co., Ltd made a donation to The Thai Red Cross AIDS Research Center for HIV Prevention Fund

On February 17, 2021 at The Thai Red Cross AIDS Research Center, Mr. Charoensuth Ngoenprasopsuk, President…

THAI-CTU was awarded

The re-competition for the Clinical Trial Unit (CTU) grant by the National Institutes of Health (NIH)…

11th D2EFT study newsletter

D2EFT: Dolutegravir and Darunavir Evaluation in Adults Failing Therapy Update from a study site: HIV-NAT Thai…

Celebrating the career of a hero of HIV research

From: Kirby Institute The Kirby Institute celebrates the exceptional career of Emeritus Professor Praphan Phanuphak, who…

Looking back at the inception of HIV-NAT in celebration of Professor Praphan Phanuphak’s retirement

Their vision was a cross-cultural HIV research center that would conduct clinical research and intervention studies…

The World congratulates to the result of the research shows that cabotegravir injection is a good way to prevent HIV infection in MSM and Transgender group

After I heard announcement the result of effective injectable cabotegravir to prevent HIV before exposure (PrEP)…